By Ben Glickman T2 Biosystems said Thursday its Candida auris diagnostic test had received Breakthrough Device Designation from the U.S. Food and Drug.
12.07.2023 - Received record quarterly sepsis test panel orders and strengthened balance sheetLEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic . Seite 1
T2 Biosystems (TTOO) Reports Prelim Q2 Revenue of $2M streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Rating) in a research note published on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock. T2 Biosystems Price Performance Shares of T2 Biosystems stock opened at $0.11 on Tuesday. The business has a 50 day moving average price […]
StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Rating) in a report issued on Tuesday morning. The firm issued a sell rating on the medical equipment provider’s stock. T2 Biosystems Stock Down 7.0 % TTOO stock opened at $0.11 on Tuesday. The business has a 50-day moving average of $0.36 and a […]